Handbook of Clinical medicine

DOAC (p350—switch directly from LMWH) or warfarin (continue LMWH until INR >2). • Is there an underlying cause, eg thrombophilia (p374), SLE, or polycythaemia? Con- sider malignancy (take a careful history and perform a full physical examination; check CXR, FBC, LFT, Ca2+; urinalysis; consider CT abdomen/pelvis and mammogram). • If obvious remedial cause, 3 months of anticoagulation (p351) may be enough; otherwise, continue for ≥3–6 months (long term if recurrent emboli, or underlying malignancy). Prevention See p190. __OOHHCCMM__1100ee..iinnddbb 881188 0022//0055//22001177 1199::0099 seicnegremE  Management of large pulmonary embolism 819 Oxygen if hypoxic, 10–15L/min Morphine 5–10mg IV with anti-emetic if the patient is in pain or very distressed IV access and start LMWH/fondaparinux If BP give 500mL IV fl uid bolus Get ICU input Haemodynamically unstable? No Yes If persistent BP consider vasopressors, Consider thrombolysis eg dobutamine 2.5–10mcg/kg/min IV or (eg alteplase 10mg IV bolus noradrenaline; aim for systolic BP >90mmHg then IVI 90mg/2h) Initiate long-term anticoagulation Fig 19.16 Management of large pulmonary embolism. __OOHHCCMM__1100ee..iinnddbb 881199 0022//0055//22001177 1199::0099 seicnegremE 820 Acute upper gastrointestinal bleeding Causes • Peptic ulcer disease (PUD) 35–50%. • Gastroduodenal erosions 8–15%. • Oesophagitis 5–15%. • Mallory–Weiss tear 15%. • Varices 5–10%. • Other: upper GI malignancy, vascular
